114 related articles for article (PubMed ID: 20164858)
41. Human normal T lymphocytes and lymphoid cell lines do express alternative splicing variants of human telomerase reverse transcriptase (hTERT) mRNA.
Jalink M; Ge Z; Liu C; Björkholm M; Gruber A; Xu D
Biochem Biophys Res Commun; 2007 Feb; 353(4):999-1003. PubMed ID: 17204238
[TBL] [Abstract][Full Text] [Related]
42. Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells.
Dupont J; Latouche JB; Ma C; Sadelain M
Cancer Res; 2005 Jun; 65(12):5417-27. PubMed ID: 15958591
[TBL] [Abstract][Full Text] [Related]
43. Tyrosine phosphorylation of the Tio oncoprotein is essential for transformation of primary human T cells.
Albrecht JC; Müller-Fleckenstein I; Schmidt M; Fleckenstein B; Biesinger B
J Virol; 2005 Aug; 79(16):10507-13. PubMed ID: 16051843
[TBL] [Abstract][Full Text] [Related]
44. Herpesvirus saimiri: a potential gene delivery vector (review).
Whitehouse A
Int J Mol Med; 2003 Feb; 11(2):139-48. PubMed ID: 12525867
[TBL] [Abstract][Full Text] [Related]
45. Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells.
Yang CT; Song J; Bu X; Cong YS; Bacchetti S; Rennie P; Jia WW
Gene Ther; 2003 Aug; 10(17):1494-502. PubMed ID: 12900765
[TBL] [Abstract][Full Text] [Related]
46. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
[TBL] [Abstract][Full Text] [Related]
47. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
Dalerba P; Guiducci C; Poliani PL; Cifola I; Parenza M; Frattini M; Gallino G; Carnevali I; Di Giulio I; Andreola S; Lombardo C; Rivoltini L; Schweighoffer T; Belli F; Colombo MP; Parmiani G; Castelli C
Cancer Res; 2005 Mar; 65(6):2321-9. PubMed ID: 15781646
[TBL] [Abstract][Full Text] [Related]
48. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
He LF; Wang YG; Xiao T; Zhang KJ; Li GC; Gu JF; Chu L; Tang WH; Tan WS; Liu XY
Cancer Lett; 2009 Dec; 286(2):196-205. PubMed ID: 19564073
[TBL] [Abstract][Full Text] [Related]
49. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
50. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K
Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
[TBL] [Abstract][Full Text] [Related]
51. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector.
Grassmann R; Dengler C; Müller-Fleckenstein I; Fleckenstein B; McGuire K; Dokhelar MC; Sodroski JG; Haseltine WA
Proc Natl Acad Sci U S A; 1989 May; 86(9):3351-5. PubMed ID: 2541443
[TBL] [Abstract][Full Text] [Related]
52. Frequent amplification of the telomerase reverse transcriptase gene in human tumors.
Zhang A; Zheng C; Lindvall C; Hou M; Ekedahl J; Lewensohn R; Yan Z; Yang X; Henriksson M; Blennow E; Nordenskjöld M; Zetterberg A; Björkholm M; Gruber A; Xu D
Cancer Res; 2000 Nov; 60(22):6230-5. PubMed ID: 11103775
[TBL] [Abstract][Full Text] [Related]
53. STP and Tip are essential for herpesvirus saimiri oncogenicity.
Duboise SM; Guo J; Czajak S; Desrosiers RC; Jung JU
J Virol; 1998 Feb; 72(2):1308-13. PubMed ID: 9445031
[TBL] [Abstract][Full Text] [Related]
54. Substitution of ras for the herpesvirus saimiri STP oncogene in lymphocyte transformation.
Guo J; Williams K; Duboise SM; Alexander L; Veazey R; Jung JU
J Virol; 1998 May; 72(5):3698-704. PubMed ID: 9557651
[TBL] [Abstract][Full Text] [Related]
55. Functional phenotype of transformed human alphabeta and gammadelta T cells determined by different subgroup C strains of herpesvirus Saimiri.
Fickenscher H; Bökel C; Knappe A; Biesinger B; Meinl E; Fleischer B; Fleckenstein B; Bröker BM
J Virol; 1997 Mar; 71(3):2252-63. PubMed ID: 9032360
[TBL] [Abstract][Full Text] [Related]
56. Species restriction of Herpesvirus saimiri and Herpesvirus ateles: human lymphocyte transformation correlates with distinct signaling properties of viral oncoproteins.
Katsch K; de Jong SJ; Schmidt M; Müller-Fleckenstein I; Fleckenstein B; Albrecht JC; Biesinger B
Virus Res; 2012 May; 165(2):179-89. PubMed ID: 22374337
[TBL] [Abstract][Full Text] [Related]
57. The genome of herpesvirus saimiri C488 which is capable of transforming human T cells.
Ensser A; Thurau M; Wittmann S; Fickenscher H
Virology; 2003 Sep; 314(2):471-87. PubMed ID: 14554077
[TBL] [Abstract][Full Text] [Related]
58. The product of the Herpesvirus saimiri open reading frame 1 (tip) interacts with T cell-specific kinase p56lck in transformed cells.
Biesinger B; Tsygankov AY; Fickenscher H; Emmrich F; Fleckenstein B; Bolen JB; Bröker BM
J Biol Chem; 1995 Mar; 270(9):4729-34. PubMed ID: 7876245
[TBL] [Abstract][Full Text] [Related]
59. The superantigen-homologous viral immediate-early gene ie14/vsag in herpesvirus saimiri-transformed human T cells.
Knappe A; Hiller C; Thurau M; Wittmann S; Hofmann H; Fleckenstein B; Fickenscher H
J Virol; 1997 Dec; 71(12):9124-33. PubMed ID: 9371569
[TBL] [Abstract][Full Text] [Related]
60. Transduction of Herpesvirus saimiri-Transformed T Cells with Exogenous Genes of Interest.
Martínez-Barricarte R; de Jong SJ; Markle J; de Paus R; Boisson-Dupuis S; Bustamante J; van de Vosse E; Fleckenstein B; Casanova JL
Curr Protoc Immunol; 2016 Nov; 115():7.21C.1-7.21C.12. PubMed ID: 27801513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
